鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/06/21 | 3,680 | 3,680 | 3,625 | 3,630 | -25 | -0.7% | 36,700 |
| 2023/06/20 | 3,655 | 3,665 | 3,620 | 3,655 | -5 | -0.1% | 21,000 |
| 2023/06/19 | 3,715 | 3,730 | 3,640 | 3,660 | +15 | +0.4% | 38,300 |
| 2023/06/16 | 3,630 | 3,660 | 3,600 | 3,645 | +35 | +1% | 69,100 |
| 2023/06/15 | 3,620 | 3,645 | 3,590 | 3,610 | -25 | -0.7% | 34,100 |
| 2023/06/14 | 3,655 | 3,655 | 3,610 | 3,635 | -20 | -0.5% | 38,200 |
| 2023/06/13 | 3,640 | 3,665 | 3,630 | 3,655 | +15 | +0.4% | 49,700 |
| 2023/06/12 | 3,695 | 3,715 | 3,640 | 3,640 | -65 | -1.8% | 44,600 |
| 2023/06/09 | 3,720 | 3,720 | 3,630 | 3,705 | +75 | +2.1% | 79,000 |
| 2023/06/08 | 3,550 | 3,665 | 3,550 | 3,630 | +115 | +3.3% | 99,500 |
| 2023/06/07 | 3,560 | 3,565 | 3,500 | 3,515 | -30 | -0.8% | 39,200 |
| 2023/06/06 | 3,550 | 3,555 | 3,510 | 3,545 | -5 | -0.1% | 35,700 |
| 2023/06/05 | 3,550 | 3,590 | 3,500 | 3,550 | +95 | +2.7% | 73,800 |
| 2023/06/02 | 3,400 | 3,465 | 3,400 | 3,455 | +45 | +1.3% | 23,000 |
| 2023/06/01 | 3,430 | 3,515 | 3,395 | 3,410 | +35 | +1% | 63,900 |
| 2023/05/31 | 3,425 | 3,445 | 3,350 | 3,375 | -80 | -2.3% | 99,600 |
| 2023/05/30 | 3,365 | 3,475 | 3,330 | 3,455 | +110 | +3.3% | 82,000 |
| 2023/05/29 | 3,445 | 3,445 | 3,340 | 3,345 | -40 | -1.2% | 13,800 |
| 2023/05/26 | 3,405 | 3,425 | 3,380 | 3,385 | -20 | -0.6% | 19,100 |
| 2023/05/25 | 3,480 | 3,480 | 3,400 | 3,405 | -75 | -2.2% | 21,500 |
| 2023/05/24 | 3,480 | 3,485 | 3,470 | 3,480 | ±0 | ±0% | 24,800 |
| 2023/05/23 | 3,490 | 3,500 | 3,445 | 3,480 | +10 | +0.3% | 32,500 |
| 2023/05/22 | 3,445 | 3,495 | 3,445 | 3,470 | +5 | +0.1% | 15,400 |
| 2023/05/19 | 3,440 | 3,480 | 3,440 | 3,465 | +25 | +0.7% | 23,100 |
| 2023/05/18 | 3,470 | 3,485 | 3,430 | 3,440 | +15 | +0.4% | 25,800 |
| 2023/05/17 | 3,485 | 3,490 | 3,425 | 3,425 | -65 | -1.9% | 29,300 |
| 2023/05/16 | 3,530 | 3,535 | 3,475 | 3,490 | -40 | -1.1% | 24,000 |
| 2023/05/15 | 3,490 | 3,545 | 3,490 | 3,530 | +55 | +1.6% | 31,100 |
| 2023/05/12 | 3,445 | 3,535 | 3,440 | 3,475 | +100 | +3% | 93,400 |
| 2023/05/11 | 3,355 | 3,390 | 3,350 | 3,375 | +20 | +0.6% | 20,500 |
| 2023/05/10 | 3,380 | 3,410 | 3,345 | 3,355 | -25 | -0.7% | 36,800 |
| 2023/05/09 | 3,330 | 3,385 | 3,330 | 3,380 | +85 | +2.6% | 42,400 |
| 2023/05/08 | 3,275 | 3,360 | 3,275 | 3,295 | -5 | -0.2% | 53,500 |
| 2023/05/02 | 3,350 | 3,365 | 3,285 | 3,300 | -45 | -1.3% | 37,800 |
| 2023/05/01 | 3,305 | 3,390 | 3,300 | 3,345 | -100 | -2.9% | 65,400 |
| 2023/04/28 | 3,445 | 3,515 | 3,415 | 3,445 | +50 | +1.5% | 91,400 |
| 2023/04/27 | 3,405 | 3,435 | 3,385 | 3,395 | +10 | +0.3% | 26,400 |
| 2023/04/26 | 3,400 | 3,430 | 3,380 | 3,385 | -5 | -0.1% | 39,800 |
| 2023/04/25 | 3,355 | 3,430 | 3,355 | 3,390 | +45 | +1.3% | 58,900 |
| 2023/04/24 | 3,375 | 3,375 | 3,330 | 3,345 | -5 | -0.1% | 39,500 |
| 2023/04/21 | 3,285 | 3,370 | 3,275 | 3,350 | +65 | +2% | 77,300 |
| 2023/04/20 | 3,270 | 3,290 | 3,250 | 3,285 | +50 | +1.5% | 53,500 |
| 2023/04/19 | 3,235 | 3,255 | 3,220 | 3,235 | -35 | -1.1% | 17,600 |
| 2023/04/18 | 3,280 | 3,295 | 3,260 | 3,270 | ±0 | ±0% | 15,300 |
| 2023/04/17 | 3,300 | 3,300 | 3,255 | 3,270 | -5 | -0.2% | 23,000 |
| 2023/04/14 | 3,250 | 3,280 | 3,240 | 3,275 | +35 | +1.1% | 33,900 |
| 2023/04/13 | 3,260 | 3,265 | 3,225 | 3,240 | -10 | -0.3% | 32,300 |
| 2023/04/12 | 3,240 | 3,260 | 3,225 | 3,250 | +15 | +0.5% | 32,600 |
| 2023/04/11 | 3,225 | 3,250 | 3,185 | 3,235 | +10 | +0.3% | 33,200 |
| 2023/04/10 | 3,195 | 3,225 | 3,185 | 3,225 | +30 | +0.9% | 21,700 |
351～
400
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
